Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
life sciences
national blog main
startups
3
×
clinical trials
fda
investing
achaogen
adams street partners
allosteric
antibiotics
atlas venture
atopic dermatitis
autoimmune disorders
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
boston
boston blog main
boston top stories
brace pharma
cleva pharma
drug discovery
drug resistance
drugs
dupilumab
food and drug administration
glaxosmithkline
hatteras venture partners
hotspot therapeutics
jonathan montagu
lyzz capital
macrolide pharmaceuticals
medical device
melinta therapeutics
meropenem
metabolic diseases
michael dudley
mrl ventures fund
national top stories
What
disease
3
×
therapeutics
3
×
drug
medicines
address
adds
ago
allosteric
bacteria
biopharma
building
business
clinic
company
deal
developer
elusive
established
exited
fighting
firm
hotspot
infections
infectious
launches
lung
melinta
molecules
momentum
new
pah
path
potential
products
qpex
rare
reaches
resistant
rivalry
seller
Language
unset
Current search:
disease
×
startups
×
therapeutics
×
@xconomy.com
3 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
